Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis
Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome
Plasticity of motor systems after incomplete spinal cord injury
They offer a wide range of different processing functions from image alignment to wavelet sharpening functions
US$ 21.27
US$ 27.50
US$ 26.07
